Cargando…
重组人凝血因子Ⅶa治疗16例血液病及异基因造血干细胞移植术后合并中至重度出血患者的疗效观察
OBJECTIVE: To analyze the efficacy of recombinant activated factor Ⅶ a (rF Ⅶ a) on hematonosis with moderate or severe bleeding signs. METHODS: Of total 16 cases with rF Ⅶ a treatment from May 2013 to May 2016, 8 cases received allogeneic hematopoietic stem cells transplantation (allo-HSCT) and the...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348376/ https://www.ncbi.nlm.nih.gov/pubmed/28395445 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.03.008 |